VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener

Orchestra BioMed Holdings, Inc. (OBIO) Total Return Calculator with Dividends Reinvested

Orchestra BioMed Holdings, Inc.

Popular:

The total return for Orchestra BioMed Holdings, Inc. (OBIO) stock is +59.76% over the past 12 months. So far it's down 8.82% this year. The 5-year total return is -62.28%, meaning $10,000 invested in OBIO stock 5 years ago would be worth $3,772 today. Total return includes price appreciation plus reinvesting any dividends paid out.

If you invested $10,000 in OBIO 1 year ago, it would be worth $13,693 today — you'd have gained $3,693.

With Dividends Reinvested$13,693+36.93%

Price Only (No DRIP)$13,693+36.93%

Period2025-05-08 → 2026-05-07

Price

Total Return (DRIP)

S&P 500

If You Invested $10,000 in OBIO

1Y$15,976+$5,976 (+59.8%)59.8% CAGR

3Y$2,165-$7,835 (-78.3%)-40.0% CAGR

5Y$3,772-$6,228 (-62.3%)-17.7% CAGR

10Y$3,447-$6,553 (-65.5%)-10.1% CAGR

15Y$3,447-$6,553 (-65.5%)-6.9% CAGR

20Y$3,447-$6,553 (-65.5%)-5.2% CAGR

30Y$3,447-$6,553 (-65.5%)-3.5% CAGR

Orchestra BioMed Holdings, Inc. did not pay dividends during this period. Total return = price return.

Loading OBIO total return...

As of 2026-05-08

Returns at a Glance

Period	Total Return	CAGR	Price Only	Div. Contrib.	$10K →
YTD	-8.82%	—	-8.82%	—	$9,118
1Y	+59.76%	59.76%	+59.76%	—	$15,976
3Y	-78.35%	-39.95%	-78.35%	—	$2,165
5Y	-62.28%	-17.72%	-62.28%	—	$3,772
10Y	-65.53%	-10.10%	-65.53%	—	$3,447
15Y	-65.53%	-6.85%	-65.53%	—	$3,447
20Y	-65.53%	-5.19%	-65.53%	—	$3,447
30Y	-65.53%	-3.49%	-65.53%	—	$3,447

Risk & Highlights

Best Year+12.37%2020

Worst Year-54.44%2024

Max Drawdown-34.77%2025-11-25 → 2026-01-30

Annual Returns

Year	Total Return	Price Return	Div.	S&P 500	vs S&P
2026YTD	+1.62%	+1.62%	—	+0.41%	+1.2pp
2025	-22.86%	-22.86%	—	+16.64%	-39.5pp
2024	-54.44%	-54.44%	—	+24.00%	-78.4pp
2023	-9.06%	-9.06%	—	+24.81%	-33.9pp
2022	+0.71%	+0.71%	—	-19.95%	+20.7pp

OBIO outperformed the S&P 500 by 29.38pp over the past year (+59.76% vs +30.37%).

Loading summary...

OBIO Peers' Total Return

Accurate peer set · 10 comparable names

Name	Mkt Cap	30D Rtn	YTD Total Rtn	1Y Total Rtn	Div Contrib	3Y Total Rtn	5Y Total Rtn	10Y Total Rtn
OBIOOrchestra BioMed Holdings, Inc.	$222M	-7.7%	-8.8%	+59.8%	—	-78.3%	-62.3%	-65.5%
NVCRNovoCure Limited	$1.9B	+62.6%	+28.3%	+1.1%	—	-75.7%	-91.3%	+30.3%
XTNTXtant Medical Holdings, Inc.	$80M	+28.8%	-24.0%	+10.0%	—	-12.3%	-66.1%	-97.8%
BSXBoston Scientific Corporation	$84.1B	-8.5%	-40.3%	-46.0%	—	+6.5%	+31.2%	+155.5%
MDTMedtronic plc	$99.9B	-9.8%	-18.1%	-2.8%	+3.4pp	-4.2%	-27.7%	+26.5%
ABTAbbott Laboratories	$151.3B	-14.5%	-28.9%	-33.2%	+1.8pp	-15.4%	-17.9%	+173.7%
SYKStryker Corporation	$112.7B	-11.4%	-15.2%	-22.5%	+0.9pp	+5.5%	+21.5%	+187.1%
EWEdwards Lifesciences Corporation	$47.7B	+2.4%	-3.0%	+10.3%	—	-7.0%	-10.2%	+133.4%
LIVNLivaNova PLC	$3.9B	+11.6%	+17.0%	+63.0%	—	+50.5%	-14.5%	+46.2%
BDXBecton, Dickinson and Company	$55.5B	-1.1%	+0.7%	+51.8%	+3.4pp	+5.0%	+16.9%	+80.2%
ZBHZimmer Biomet Holdings, Inc.	$16.3B	-8.8%	-7.1%	-10.4%	+1.0pp	-37.2%	-47.3%	-17.8%

Compare:OBIO vs NVCR OBIO vs XTNT OBIO vs BSX OBIO vs NVCR vs XTNT

About OBIO Dividend Returns

Orchestra BioMed Holdings, Inc. (OBIO) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.

How We Calculate Total Return

Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.

Frequently Asked Questions

Q1What is the total return of OBIO over the past year?

Orchestra BioMed Holdings, Inc. (OBIO) delivered a return of 59.76% over the past year. Since OBIO does not currently pay dividends, the total return equals the price-only return.

Q2How much would $10,000 invested in OBIO be worth today?

A $10,000 investment in Orchestra BioMed Holdings, Inc. one year ago would be worth $15,976 today, representing a gain of $5,976.

Q3Does OBIO pay dividends?

Orchestra BioMed Holdings, Inc. (OBIO) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For OBIO, the total return equals the price-only return.

Q4Did OBIO beat the S&P 500?

Yes, Orchestra BioMed Holdings, Inc. (OBIO) outperformed the S&P 500 by 29.38 percentage points over the past year. OBIO delivered a total return of 59.76%, compared to the S&P 500's 30.37%. This 29.38pp alpha means investors in OBIO earned more than a passive S&P 500 index fund.

Q5What is OBIO's worst drawdown?

Orchestra BioMed Holdings, Inc. (OBIO) experienced a maximum drawdown of -34.77% over the past year, declining from its peak on 2025-11-25 to its trough on 2026-01-30. The stock has not yet fully recovered to its prior peak. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Q6What is OBIO's long-term total return over 10, 20, or 30 years?

Here are Orchestra BioMed Holdings, Inc. (OBIO)'s long-term returns with dividends reinvested. Over 10 years, the total return is -65.5% (-10.1% CAGR) — $10,000 would have grown to $3,447. Over 20 years: -65.5% total return (-5.2% CAGR) — $10,000 → $3,447. Over 30 years: -65.5% total return (-3.5% CAGR) — $10,000 → $3,447. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Q7What was OBIO's best and worst year?

Orchestra BioMed Holdings, Inc.'s best calendar year was 2020 with a total return of 12.4%. Its worst year was 2024 with a total return of -54.4%. This range shows the volatility investors should expect — the difference between the best and worst year is 66.8 percentage points.